Academic Journal
Environmental Endocrine-Disrupting Chemicals and Metabolic Dysfunction-Associated Steatotic Liver Disease.
| Τίτλος: | Environmental Endocrine-Disrupting Chemicals and Metabolic Dysfunction-Associated Steatotic Liver Disease. |
|---|---|
| Συγγραφείς: | Zhao Y; National Clinical Research Center for Endocrine and Metabolic Diseases, Matabolic Syndrome Research Center, Department of Geriatrics, The Second Xiangya Hospital of Central South University, Changsha, China., He H; National Clinical Research Center for Endocrine and Metabolic Diseases, Matabolic Syndrome Research Center, Department of Geriatrics, The Second Xiangya Hospital of Central South University, Changsha, China., Zeng J; Department of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China., Zhang J; National Clinical Research Center for Endocrine and Metabolic Diseases, Matabolic Syndrome Research Center, Department of Geriatrics, The Second Xiangya Hospital of Central South University, Changsha, China. |
| Πηγή: | Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2026 Aug; Vol. 46 (8), pp. e70793. |
| Τύπος έκδοσης: | Journal Article; Meta-Analysis; Systematic Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE |
| Imprint Name(s): | Publication: Malden, MA : Wiley-Blackwell Original Publication: Oxford, UK : Blackwell Munksgaard, c2003- |
| Ιατρικοί όροι (MeSH): | Endocrine Disruptors*/adverse effects , Endocrine Disruptors*/toxicity , Non-alcoholic Fatty Liver Disease*/epidemiology , Non-alcoholic Fatty Liver Disease*/chemically induced , Environmental Exposure*/adverse effects , Environmental Pollutants*, Humans ; Prevalence |
| Περίληψη: | Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed non-alcoholic fatty liver disease (NAFLD), represents the most prevalent chronic liver condition worldwide, affecting approximately 25%-30% of the global adult population. Endocrine-disrupting chemicals (EDCs)-including phthalates, bisphenols, per- and polyfluoroalkyl substances (PFAS), persistent organic pollutants (POPs) and heavy metals-are ubiquitous environmental contaminants with established metabolic toxicity. However, the quantitative association between EDC exposure and MASLD prevalence remains incompletely characterised. We conducted a systematic review and meta-analysis to synthesise the current epidemiological evidence on this association. Methods: We systematically searched PubMed, Embase, Web of Science and the Cochrane Library from inception through January 2026, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines (PROSPERO: CRD420261298624). Studies were eligible if they reported quantitative associations between measured EDC exposures and MASLD/NAFLD/metabolic-associated fatty liver disease (MAFLD) outcomes in human populations. Two investigators independently screened records, extracted data and assessed methodological quality using a customised Newcastle-Ottawa Scale (NOS). Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models. Heterogeneity was assessed via the I2 statistic. Funnel plot asymmetry and Egger's test were used to evaluate publication bias. Sensitivity analyses were performed using leave-one-out methods. Results: Of 427 records identified, 42 studies encompassing diverse global populations met inclusion criteria and were incorporated into the quantitative synthesis. The meta-analysis demonstrated that: Phthalates: mono (2-ethyl-5-carboxypentyl) phthalate (MECPP; weighted mean difference [WMD]: 2.40, 95% CI: 0.71-4.09), mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP; WMD: 2.46, 95% CI: 0.81-4.10) and monobenzyl phthalate (MBzP; WMD: 1.84, 95% CI: 0.10-3.59) showed significant positive associations with MASLD prevalence; pooled analysis of phthalate mixtures yielded an overall OR of 1.17 (95% CI: 1.13-1.21; I2 = 41.4%). Bisphenols: pooled analysis demonstrated a significant positive association with MASLD (OR: 1.29, 95% CI: 1.09-1.50; I2 = 73.0%), with bisphenol A (BPA; OR: 1.32, 95% CI: 0.92-1.72), bisphenol S (BPS; OR: 1.47, 95% CI: 0.96-1.98) and bisphenol F (BPF; OR: 1.19, 95% CI: 0.77-1.61) contributing to this effect. PFAS: the overall pooled effect was OR 0.95 (95% CI: 0.91-1.00; I2 = 22.9%). POPs: the overall OR was 1.30 (95% CI: 1.22-1.37; I2 = 29.2%), with organochlorine pesticides (OCPs; OR: 1.30, 95% CI: 1.19-1.42) and polychlorinated biphenyl (PCB)/OCP combinations demonstrating significant associations. Heavy metals/metalloids: mercury (Hg) demonstrated the strongest positive association (OR: 1.60, 95% CI: 1.15-2.04; I2 = 87.3%), followed by lead (Pb; OR: 1.40, 95% CI: 1.02-1.78) and cadmium (Cd; OR: 1.30, 95% CI: 1.09-1.51; I2 = 79.2%); the overall metals pooled OR was 1.26 (95% CI: 1.16-1.37; I2 = 79.9%). Methodological quality assessed by NOS ranged from 6 to 9 points, with the majority of studies scoring ≥ 7. Conclusions: This meta-analysis of observational studies suggests that environmental exposure to several major EDC classes-including phthalates, bisphenols, persistent organic pollutants and certain heavy metals-is associated with a higher prevalence of MASLD, although the magnitude and consistency of associations vary substantially across chemical classes and individual compounds. Findings for PFAS were heterogeneous and compound-specific. Given the predominantly cross-sectional nature of the available evidence and the considerable between-study heterogeneity, causal inference cannot be drawn. These findings should be interpreted as hypothesis-generating and underscore the need for prospective multi-pollutant studies and mechanistic investigations to clarify the role of EDCs in MASLD pathogenesis. (© 2026 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.) |
| References: | J. Liu, I. Ayada, X. Zhang, et al., “Estimating Global Prevalence of Metabolic Dysfunction‐Associated Fatty Liver Disease in Overweight or Obese Adults,” Clinical Gastroenterology and Hepatology 20, no. 3 (2022): e573–e582. Y. Fouad, M. Alboraie, and G. Shiha, “Epidemiology and Diagnosis of Metabolic Dysfunction‐Associated Fatty Liver Disease,” Hepatology International 18, no. Suppl 2 (2024): 827–833. Z. Lu, W. Shao, and J. Song, “The Transition From NAFLD to MASLD and Its Impact on Clinical Practice and Outcomes,” Journal of Hepatology 81, no. 4 (2024): e155–e156. J. Bilson, A. Mantovani, C. D. Byrne, et al., “Steatotic Liver Disease, MASLD and Risk of Chronic Kidney Disease,” Diabetes & Metabolism 50, no. 1 (2024): 101506. E. Han, B. W. Lee, E. S. Kang, et al., “Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Population‐Based Cohort Study,” Metabolism 152 (2024): 155789. M. C. C. Cheah, H. Crane, and J. George, “Global Prevalence, Metabolic Characteristics, and Outcomes of Lean‐MAFLD: A Systematic Review and Meta‐Analysis,” Hepatology International 19, no. 3 (2025): 607–618. T. T. Schug, A. Janesick, B. Blumberg, et al., “Endocrine Disrupting Chemicals and Disease Susceptibility,” Journal of Steroid Biochemistry and Molecular Biology 127, no. 3–5 (2011): 204–215. E. Mentsiou Nikolaou, P. Kalafati, I, and G. V. Dedoussis, “The Interplay Between Endocrine‐Disrupting Chemicals and the Epigenome Towards Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Comprehensive Review,” Nutrients 16, no. 8 (2024): 1124. H. Chen, H. Cui, and Z. Meng, “The Nexus of Environmental Endocrine‐Disrupting Chemical Exposure and Metabolic Dysfunction‐Associated Steatotic Liver Disease: An Emerging Public Health Challenge,” Ecotoxicology and Environmental Safety 309 (2026): 119513. R. Lei, B. Xue, X. Tian, et al., “The Association Between Endocrine Disrupting Chemicals and MAFLD: Evidence From NHANES Survey,” Ecotoxicology and Environmental Safety 256 (2023): 114836. H. Zou, W. Pan, and X. Sun, “Assessment of the Diagnostic Efficacy of Five Non‐Invasive Tests for MASLD: External Validation Utilizing Data From Two Cohorts,” Frontiers in Nutrition 12 (2025): 1571487. J. Sun, S. Yang, Y. Zhang, W. Xiang, and X. Jiang, “Relationship Between Phthalates Exposures and Metabolic Dysfunction‐Associated Fatty Liver Disease in United States Adults,” PLoS One 19, no. 4 (2024): e0301097. Q. Q. Chen, L. You, P. W. Guan, et al., “Risk Analysis of Serum Chemical Residues for Metabolic Associated Fatty Liver Disease Based on Exposome‐Lipidome Wide Association Study,” Se Pu 42, no. 2 (2024): 164–175. X. Chen, F. Tian, J. Wu, et al., “Associations of Phthalates With NAFLD and Liver Fibrosis: A Nationally Representative Cross‐Sectional Study From NHANES 2017 to 2018,” Frontiers in Nutrition 9 (2022): 1059675. W. Li, H. Xiao, H. Wu, et al., “Analysis of Environmental Chemical Mixtures and Nonalcoholic Fatty Liver Disease: NHANES 1999–2014,” Environmental Pollution 311 (2022): 119915. E. J. Yang, B. S. Choi, and Y. J. Yang, “Risk of Nonalcoholic Fatty Liver Disease Is Associated With Urinary Phthalate Metabolites Levels in Adults With Subclinical Hypothyroidism: Korean National Environmental Health Survey (KoNEHS) 2012–2014,” International Journal of Environmental Research and Public Health 19, no. 6 (2022): 3267. Y. J. Yang, T. Kim, and Y. P. Hong, “Urinary Phthalate Levels Associated With the Risk of Nonalcoholic Fatty Liver Disease in Adults: The Korean National Environmental Health Survey (KoNEHS) 2012–2014,” International Journal of Environmental Research and Public Health 18, no. 11 (2021): 6035. S. Cai, J. Fan, J. Ye, et al., “Phthalates Exposure Is Associated With Non‐Alcoholic Fatty Liver Disease Among US Adults,” Ecotoxicology and Environmental Safety 224 (2021): 112665. R. Jin, R. McConnell, C. Catherine, et al., “Perfluoroalkyl Substances and Severity of Nonalcoholic Fatty Liver in Children: An Untargeted Metabolomics Approach,” Environment International 134 (2020): 105220. L. A. Darrow, A. C. Groth, A. Winquist, et al., “Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid‐Ohio Valley Community,” Environmental Health Perspectives 124, no. 8 (2016): 1227–1233. X. Fu, J. He, D. Zheng, et al., “Association of Endocrine Disrupting Chemicals Levels in Serum, Environmental Risk Factors, and Hepatic Function Among 5‐ To 14‐Year‐Old Children,” Toxicology 465 (2022): 153011. S. J. An, E. J. Yang, S. Oh, et al., “The Association Between Urinary Bisphenol A Levels and Nonalcoholic Fatty Liver Disease in Korean Adults: Korean National Environmental Health Survey (KoNEHS) 2015–2017,” Environmental Health and Preventive Medicine 26, no. 1 (2021): 91. D. Kim, E. R. Yoo, A. A. Li, et al., “Elevated Urinary Bisphenol A Levels Are Associated With Non‐Alcoholic Fatty Liver Disease Among Adults in the United States,” Liver International 39, no. 7 (2019): 1335–1342. S. G. Verstraete, J. M. Wojcicki, E. R. Perito, et al., “Bisphenol a Increases Risk for Presumed Non‐Alcoholic Fatty Liver Disease in Hispanic Adolescents in NHANES 2003–2010,” Environmental Health 17, no. 1 (2018): 12. Q. Liu, G. Fan, J. Bi, et al., “Associations of Polychlorinated Biphenyls and Organochlorine Pesticides With Metabolic Dysfunction‐Associated Fatty Liver Disease Among Chinese Adults: Effect Modification by Lifestyle,” Environmental Research 240, no. Pt 2 (2024): 117507. K. Hakkarainen, P. Rantakokko, J. Koponen, et al., “Persistent Organic Pollutants Associate With Liver Disease in a Finnish General Population Sample,” Liver International 43, no. 10 (2023): 2177–2185. H. Sang, K. N. Lee, C. H. Jung, et al., “Association Between Organochlorine Pesticides and Nonalcoholic Fatty Liver Disease in the National Health and Nutrition Examination Survey 2003–2004,” Scientific Reports 12, no. 1 (2022): 11590. Y. Guo, X. Guan, Y. You, et al., “Association Between Organochlorine Pesticides and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Findings From the Dongfeng‐Tongji Cohort,” Environment International 201 (2025): 109571. P. Rantakokko, V. Männistö, R. Airaksinen, et al., “Persistent Organic Pollutants and Non‐Alcoholic Fatty Liver Disease in Morbidly Obese Patients: A Cohort Study,” Environmental Health 14 (2015): 79. R. Yang, Q. Jiang, W. Liu, et al., “Serum Polychlorinated Biphenyls as a Risk Factor for MASLD: Exploring the Association and Underlying Mechanisms,” Science of the Total Environment 981 (2025): 179617. M. Cave, S. Appana, M. Patel, et al., “Polychlorinated Biphenyls, Lead, and Mercury Are Associated With Liver Disease in American Adults: NHANES 2003–2004,” Environmental Health Perspectives 118, no. 12 (2010): 1735–1742. J. Zou, Q. Gu, and D. Gu, “Association Between Phthalates Exposure and Non‐Alcoholic Fatty Liver Disease Under Different Diagnostic Criteria: A Cross‐Sectional Study Based on NHANES 2017 to 2018,” Frontiers in Public Health 12 (2024): 1407976. J. Li, R. Chen, P. Liu, et al., “Association of Di(2‐Ethylhexyl) Terephthalate and Its Metabolites With Nonalcoholic Fatty Liver Disease: An Epidemiology and Toxicology Study,” Environmental Science & Technology 58, no. 19 (2024): 8182–8193. Y. He, J. Zou, T. Hong, et al., “Association Between Di‐2‐Ethylhexyl Phthalate and Nonalcoholic Fatty Liver Disease Among US Adults: Mediation Analysis of Body Mass Index and Waist Circumference in the NHANES,” Food and Chemical Toxicology 179 (2023): 113968. M. Albeldawi, R. Lopez, and N. Zein, “Is There an Association Between Bisphenol a and Liver Disease?: Results From NHANES 2005‐2006,” Gastroenterology 140 (2011): 728. W. Cheng, M. Li, L. Zhang, et al., “Close Association of PFASs Exposure With Hepatic Fibrosis Than Steatosis: Evidences From NHANES 2017–2018,” Annals of Medicine 55, no. 1 (2023): 2216943. S. Zhang and X. Jiang, “Association Between Perfluoroalkyl Substances Exposure and the Prevalence of Nonalcoholic Fatty Liver Disease in the Different Sexes: A Study From the National Health and Nutrition Examination Survey 2005–2018,” Environmental Science and Pollution Research International 30, no. 15 (2023): 44292–44303. H. D. Momo, C. S. Alvarez, M. P. Purdue, et al., “Associations of Per‐ and Polyfluoroalkyl Substances and Nonalcoholic Fatty Liver Disease in the United States Adult Population, 2003–2018,” Environmental Epidemiology 8, no. 1 (2024): e284. Z. Wu, T. Ouyang, H. Liu, et al., “Perfluoroalkyl Substance (PFAS) Exposure and Risk of Nonalcoholic Fatty Liver Disease in the Elderly: Results From NHANES 2003–2014,” Environmental Science and Pollution Research International 30, no. 23 (2023): 64342–64351. X. Zhang, L. Zhao, A. Ducatman, et al., “Association of Per‐ and Polyfluoroalkyl Substance Exposure With Fatty Liver Disease Risk in US Adults,” JHEP Reports 5, no. 5 (2023): 100694. J. Peng, L. L. Du, and Q. L. Ma, “Serum Glycolipids Mediate the Relationship of Urinary Bisphenols With NAFLD: Analysis of a Population‐Based, Cross‐Sectional Study,” Environmental Health 21, no. 1 (2023): 124. J. Liang, C. Xu, J. Xu, et al., “PPARα Senses Bisphenol S to Trigger EP300‐Mediated Autophagy Blockage and Hepatic Steatosis,” Environmental Science & Technology 57, no. 51 (2023): 21581–21592. R. Chen, Y. Xu, C. Xu, et al., “Associations Between Mercury Exposure and the Risk of Nonalcoholic Fatty Liver Disease (NAFLD) in US Adolescents,” Environmental Science and Pollution Research International 26, no. 30 (2019): 31384–31391. S. Han, G. H. Sung, S. Lee, et al., “Serum Cadmium Is Associated With Hepatic Steatosis and Fibrosis: Korean National Health and Nutrition Examination Survey Data IV–VII,” Medicine (Baltimore) 101, no. 4 (2022): e28559. O. Hyder, M. Chung, D. Cosgrove, et al., “Cadmium Exposure and Liver Disease Among US Adults,” Journal of Gastrointestinal Surgery 17, no. 7 (2013): 1265–1273. Y. Li, C. Chen, L. Lu, et al., “Cadmium Exposure in Young Adulthood Is Associated With Risk of Nonalcoholic Fatty Liver Disease in Midlife,” Digestive Diseases and Sciences 67, no. 2 (2022): 689–696. E. Park, J. Kim, B. Kim, and E. Y. Park, “Association Between Environmental Exposure to Cadmium and Risk of Suspected Non‐Alcoholic Fatty Liver Disease,” Chemosphere 266 (2021): 128947. B. Wahlang, S. Appana, K. C. Falkner, et al., “Insecticide and Metal Exposures Are Associated With a Surrogate Biomarker for Non‐Alcoholic Fatty Liver Disease in the National Health and Nutrition Examination Survey 2003‐2004,” Environmental Science and Pollution Research International 27, no. 6 (2020): 6476–6487. H. Wan, Y. Wang, H. Zhang, et al., “Chronic Lead Exposure Induces Fatty Liver Disease Associated With the Variations of Gut Microbiota,” Ecotoxicology and Environmental Safety 232 (2022): 113257. Z. Xie, R. Aimuzi, M. Si, et al., “Associations of Metal Mixtures With Metabolic‐Associated Fatty Liver Disease and Non‐Alcoholic Fatty Liver Disease: NHANES 2003–2018,” Frontiers in Public Health 11 (2023): 1133194. Y. J. Yang, E. J. Yang, K. Park, et al., “Association Between Blood Mercury Levels and Non‐Alcoholic Fatty Liver Disease in Non‐Obese Populations: The Korean National Environmental Health Survey (KoNEHS) 2012–2014,” International Journal of Environmental Research and Public Health 18, no. 12 (2021): 6412. H. Zhai, C. Chen, N. Wang, et al., “Blood Lead Level Is Associated With Non‐Alcoholic Fatty Liver Disease in the Yangtze River Delta Region of China in the Context of Rapid Urbanization,” Environmental Health 16, no. 1 (2017): 93. M. J. Silva, E. Samandar, J. L. J. Preau, J. L. Preau, L. L. Needham, and A. M. Calafat, “Urinary Oxidative Metabolites of Di(2‐Ethylhexyl) Phthalate in Humans,” Toxicology 219, no. 1–3 (2006): 22–32. H. M. Koch, R. Preuss, and J. Angerer, “Di(2‐Ethylhexyl)phthalate (DEHP): Human Metabolism and Internal Exposure—An Update and Latest Results,” International Journal of Andrology 29, no. 1 (2006): 155–165, 181–185. W. Zhang, X. Y. Shen, W. W. Zhang, H. Chen, W. P. Xu, and W. Wei, “The Effects of Di 2‐Ethyl Hexyl Phthalate (DEHP) on Cellular Lipid Accumulation in HepG2 Cells and Its Potential Mechanisms in the Molecular Level,” Toxicology Mechanisms and Methods 27, no. 4 (2017): 245–252. Y. Ito, O. Yamanoshita, N. Asaeda, et al., “Di(2‐Ethylhexyl)phthalate Induces Hepatic Tumorigenesis Through a Peroxisome Proliferator‐Activated Receptor Alpha‐Independent Pathway,” Journal of Occupational Health 49, no. 3 (2007): 172–182. Q. Li, Y. Zhang, H. Zha, et al., “Short‐Term Subacute Di(2‐Ethylhexyl) Phthalate Exposure Disrupts Gut Microbiota, Metabolome, Liver Transcriptome, Immunity, and Induces Liver Injury in Rats,” Ecotoxicology and Environmental Safety 292 (2025): 117948. W. He, Z. Gao, S. Liu, et al., “G Protein‐Coupled Estrogen Receptor Activation by Bisphenol‐A Disrupts Lipid Metabolism and Induces Ferroptosis in the Liver,” Environmental Pollution 334 (2023): 122211. M. Maniradhan and L. Calivarathan, “Bisphenol A‐Induced Endocrine Dysfunction and Its Associated Metabolic Disorders,” Endocrine, Metabolic & Immune Disorders Drug Targets 23, no. 4 (2023): 515–529. S. Ahmed and E. Atlas, “Bisphenol S‐ and Bisphenol A‐Induced Adipogenesis of Murine Preadipocytes Occurs Through Direct Peroxisome Proliferator‐Activated Receptor Gamma Activation,” International Journal of Obesity 40, no. 10 (2016): 1566–1573. E. Panieri, K. Baralic, D. Djukic‐Cosic, et al., “PFAS Molecules: A Major Concern for the Human Health and the Environment,” Toxics 10, no. 2 (2022): 44. M. G. Evich, M. J. B. Davis, J. P. McCord, et al., “Per‐ and Polyfluoroalkyl Substances in the Environment,” Science 375, no. 6580 (2022): eabg9065. C. J. Wolf, M. L. Takacs, J. E. Schmid, et al., “Activation of Mouse and Human Peroxisome Proliferator‐Activated Receptor Alpha by Perfluoroalkyl Acids of Different Functional Groups and Chain Lengths,” Toxicological Sciences 106, no. 1 (2008): 162–171. S. Tao, W. Liu, Y. Li, et al., “Organochlorine Pesticides Contaminated Surface Soil as Reemission Source in the Haihe Plain, China,” Environmental Science & Technology 42, no. 22 (2008): 8395–8400. X. Coumoul, M. Diry, and R. Barouki, “PXR‐Dependent Induction of Human CYP3A4 Gene Expression by Organochlorine Pesticides,” Biochemical Pharmacology 64, no. 10 (2002): 1513–1519. Y. Yamazaki, S. Kakizaki, N. Horiguchi, et al., “Role of Nuclear Receptor CAR in Carbon Tetrachloride‐Induced Hepatotoxicity,” World Journal of Gastroenterology 11, no. 38 (2005): 5966–5972. T. Rezen, V. Tamasi, A. Lövgren‐Sandblom, et al., “Effect of CAR Activation on Selected Metabolic Pathways in Normal and Hyperlipidemic Mouse Livers,” BMC Genomics 10 (2009): 384. H. Fujita, C. Nishitani, and K. Ogawa, “Lead, Chemical Porphyria, and Heme as a Biological Mediator,” Tohoku Journal of Experimental Medicine 196, no. 2 (2002): 53–64. T. Y. Jin, L. J. Lei, and X. L. Chang, “Evaluation for Risk of Health Effect on Cadmium Exposure,” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 24, no. 1 (2006): 1–2. W. Wang, S. Cheng, and D. Zhang, “Association of Inorganic Arsenic Exposure With Liver Cancer Mortality: A Meta‐Analysis,” Environmental Research 135 (2014): 120–125. K. Islam, A. Haque, R. Karim, et al., “Dose‐Response Relationship Between Arsenic Exposure and the Serum Enzymes for Liver Function Tests in the Individuals Exposed to Arsenic: A Cross Sectional Study in Bangladesh,” Environmental Health 10 (2011): 64. |
| Contributed Indexing: | Keywords: endocrine‐disrupting chemicals; environmental exposure; hepatic steatosis; metabolic dysfunction‐associated steatotic liver disease; meta‐analysis Local Abstract: [plain-language-summary] Fatty liver disease is now the most common liver problem worldwide, and it is usually linked to obesity, diabetes and unhealthy diets. In this study, we combined the results of 42 previous studies and found that everyday exposure to certain man‐made chemicals—such as plastics‐related compounds (phthalates and bisphenols), long‐lasting industrial pollutants and heavy metals like mercury, lead and cadmium—is associated with a higher chance of having fatty liver disease. These findings suggest that, alongside diet and lifestyle, reducing contact with these common environmental chemicals may be important for protecting liver health. |
| Substance Nomenclature: | 0 (Endocrine Disruptors) 0 (Environmental Pollutants) |
| Entry Date(s): | Date Created: 20260709 Date Completed: 20260709 Latest Revision: 20260726 |
| Update Code: | 20260726 |
| PubMed Central ID: | PMC13348493 |
| DOI: | 10.1111/liv.70793 |
| PMID: | 42423535 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!